Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Renal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02089802
What this trial is testing

Optimizing Pazopanib Exposure in RCC Patients

Who this might be right for
Locally Advanced Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Interessenverband zur Qualitätssicherung der Arbeit niedergelassener Uro-Onkologen in Deutschland e. 6
Large-scale testing (Phase 3)Ended earlyNCT00540969
What this trial is testing

Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases

Who this might be right for
Kidney CancerMelanoma (Skin)Metastatic Cancer+2 more
Alliance for Clinical Trials in Oncology 3
Early research (Phase 1)Looking for participantsNCT07369505
What this trial is testing

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Who this might be right for
Breast Cancer MetastaticRenal Cell Carcinoma (RCC)Neuroendocrine Tumors+2 more
SAPU NANO (US) LLC 27
Testing effectiveness (Phase 2)Ended earlyNCT04495894
What this trial is testing

Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma

Who this might be right for
Non-small Cell Lung CancerRenal Cell Carcinoma
Emory University 68
Not applicableStudy completedNCT05230186
What this trial is testing

A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.

Who this might be right for
Solid Tumor, Adult
TScan Therapeutics, Inc. 12
Not applicableUnknownNCT04946266
What this trial is testing

Prospective Validation of the Prognostic Value of Long Non-coding MFI2-AS1 RNA in Localized Clear Cell Kidney Cancers

Who this might be right for
Kidney Cancer
University Hospital, Strasbourg, France 260
Testing effectiveness (Phase 2)Study completedNCT05485896
What this trial is testing

Neoadjuvant Therapy of Pembrolizumab Plus Lenvatinib in Advanced RCC

Who this might be right for
Renal Cell Carcinoma
Tianjin Medical University Second Hospital 23
Large-scale testing (Phase 3)Ended earlyNCT04588246
What this trial is testing

Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+9 more
NRG Oncology 19
Large-scale testing (Phase 3)Active Not RecruitingNCT01224288
What this trial is testing

Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble

Who this might be right for
Renal Cell Carcinoma
M.D. Anderson Cancer Center 120
Testing effectiveness (Phase 2)Study completedNCT01435122
What this trial is testing

Axitinib in Advanced Carcinoid Tumors

Who this might be right for
Carcinoid Tumor
H. Lee Moffitt Cancer Center and Research Institute 30
Not applicableLooking for participantsNCT07820566
What this trial is testing

Development of a Preclinical 3D Vascularized and Perfused Tumoroid Model in Oncology and Urology Developed From Patient Tumors (Kidney, Bladder, and Prostate Cancers)

Who this might be right for
Kidney CancersBladder CancerProstate Cancer
University Hospital, Strasbourg, France 100
Testing effectiveness (Phase 2)Study completedNCT03136627
What this trial is testing

Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC

Who this might be right for
Carcinoma, Renal Cell
AVEO Pharmaceuticals, Inc. 28
Not applicableStudy completedNCT04873180
What this trial is testing

Significance of Immunohistochemical Expression of Survivin in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Sohag University 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06577961
What this trial is testing

Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients

Who this might be right for
Kidney CancerRCCRenal Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 37
Testing effectiveness (Phase 2)UnknownNCT00039169
What this trial is testing

BAY 59-8862 in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
Theradex
Large-scale testing (Phase 3)Active Not RecruitingNCT03793166
What this trial is testing

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Lymph Nodes+6 more
National Cancer Institute (NCI) 1,175
Testing effectiveness (Phase 2)Study completedNCT00045279
What this trial is testing

PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Large-scale testing (Phase 3)Study completedNCT00492986
What this trial is testing

An Open-Label, Non-Comparative, Phase III Study of the Raf-Kinase Inhibitor BAY 43-9006 as a Subsequent to First-Line Therapy in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Bayer 1,150
Not applicableActive Not RecruitingNCT04120805
What this trial is testing

Random Evaluation of Patients Who Have Had Laparoscopic Partial Nephrectomy

Who this might be right for
Kidney Cancer
University of Chicago 178
Next Page